Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Kronenberg

Showing results (1-10 of 450) with videos related to

Pageof 45
Sort By:
European Heart Journal|August 18, 2022
Lipoprotein(a) and aortic valve stenosis: work in progressFlorian Kronenberg
Expert Review of Cardiovascular Therapy|September 8, 2004
Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney diseaseFlorian Kronenberg
Kidney International|October 24, 2021
Telomere length and chronic kidney disease: cause or consequence?Florian Kronenberg
Experimental Gerontology|October 31, 2007
Genome-wide association studies in aging-related processes such as diabetes mellitus, atherosclerosis and cancerFlorian Kronenberg
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 14, 2005
Dyslipidemia and nephrotic syndrome: recent advancesFlorian Kronenberg
Praxis|August 24, 2017
Florian Kronenberg
Handbook of Experimental Pharmacology|July 1, 2021
Lipoprotein(a)Florian Kronenberg
Atherosclerosis|November 24, 2022
Studies on lipoprotein(a) and outcomes in peripheral arterial disease: One must not compare apples with pearsFlorian Kronenberg
Clinical Research in Cardiology Supplements|March 13, 2019
Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene regionFlorian Kronenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2011
APOL1 variants and kidney disease. There is no such thing as a free lunchFlorian Kronenberg
Pageof 45

Showing results (1-10 of 450) with videos related to

Sort By:
Pageof 45
European Heart Journal|August 18, 2022
Lipoprotein(a) and aortic valve stenosis: work in progressFlorian Kronenberg
Expert Review of Cardiovascular Therapy|September 8, 2004
Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney diseaseFlorian Kronenberg
Kidney International|October 24, 2021
Telomere length and chronic kidney disease: cause or consequence?Florian Kronenberg
Experimental Gerontology|October 31, 2007
Genome-wide association studies in aging-related processes such as diabetes mellitus, atherosclerosis and cancerFlorian Kronenberg
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 14, 2005
Dyslipidemia and nephrotic syndrome: recent advancesFlorian Kronenberg
Praxis|August 24, 2017
Florian Kronenberg
Handbook of Experimental Pharmacology|July 1, 2021
Lipoprotein(a)Florian Kronenberg
Atherosclerosis|November 24, 2022
Studies on lipoprotein(a) and outcomes in peripheral arterial disease: One must not compare apples with pearsFlorian Kronenberg
Clinical Research in Cardiology Supplements|March 13, 2019
Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene regionFlorian Kronenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2011
APOL1 variants and kidney disease. There is no such thing as a free lunchFlorian Kronenberg
Pageof 45